Clinical phenotypes of severe asthma;Fenótipos clínicos de asma grave

Jornal Brasileiro de Pneumologia

Volumn 34, Issue 9, 2008, Pages 646-653

  Alves, Roseliane De Souza Araújo ^a,b   Vianna, Flávia De Almeida Filardo ^a   Pereira, Carlos Alberto De Castro ^a  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Asthma; Asthma prevention control; Asthma treatment

Indexed keywords

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; EPIDEMIOLOGY; FEMALE; GASTROESOPHAGEAL REFLUX; HOSPITALIZATION; HUMAN; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHENOTYPE; STATISTICS; TREATMENT REFUSAL;

AIRWAY OBSTRUCTION; ASTHMA; EPIDEMIOLOGIC METHODS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHENOTYPE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT REFUSAL;

EID: 55949096873     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/S1806-37132008000900003     Document Type: Article

References (30)

1. Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J. 1999;13(5):1198-208.
2. Araujo AC, Ferraz E, Borges MC, Terra-Filho J, Vianna EO. Investigation of factors associated with difficult-to-control asthma. J Bras Pneumol. 2007;33(5):495-501.
3. Sociedade Brasileira de Pneumologia e Tisiologia. II Consenso Brasileiro no Manejo da Asma. J Pneumol. 1999;24(4):1-167.
4. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J. 2003;22(3):470-7.
5. Holgate ST, Holloway J, Wilson S, Howarth PH, Haitchi HM, Babu S, et al. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J Allergy Clin Immunol. 2006 ;117(3):496-506; quiz 507.
6. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2006;117(3):522-43.
7. Sutherland ER. Nocturnal asthma. J Allergy Clin Immunol. 2005 Dec;116(6):1179-86; quiz 1187.
8. Wenzel S. Physiologic and pathologic abnormalities in severe asthma. Clin Chest Med. 2006;27(1):29-40, v.
9. Wenzel SE, Balzar S, Cundall M, Chu HW. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol. 2003;111(6):1345-52.
10. Garcia G, Adler M, Humbert M. Difficult asthma. Allergy. 2003;58(2):114-21.
11. Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, et al. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J. 2004;24(1):122-8.
12. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med. 2001;164(5):744-8.
13. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in airway inflammation inpatients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(3):418-24.
14. Obase Y, Matsuse H, Shimoda T, Haahtela T, Kohno S. Pathogenesis and management of aspirin-intolerant asthma. Treat Respir Med. 2005;4(5):325-36. Treat Respir Med. 2005;4(5):325-36.
15. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol. 1999;104(1):5-13.
16. Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L, et al. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2005;116(5):970-5.
17. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med. 2000;162(6):2341-51.
18. Cochrane GM, Horne R, Chanez P. Compliance in asthma. Respir Med. 1999;93(11):763-9.
19. Wenzel SE. A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma. Eur Respir J. 2003;22(3):397-8.
20. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF, et al. Systematic assessment of difficult-to-treat asthma. Eur Respir J. 2003;22(3):478-83.
21. Irwin RS, Curley FJ, French CL. Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol. Chest. 1993;103(6):1662-9.
22. Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole. Chest. 1999;116(5):1257-64. Erratum in: Chest 2001;120(2):691.
23. Leggett JJ, Johnston BT, Mills M, Gamble J, Heaney LG. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest. 2005;127(4):1227-31.
24. Littner MR, Leung FW, Ballard ED 2nd, Huang B, Samra NK; Lansoprazole Asthma Study Group. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest. 2005;128(3):1128-35.
25. ten Brinke A, Grootendorst DC, Schmidt JT, De Bruïne FT, van Buchem MA, Sterk PJ, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol. 2002;109(4):621-6.
26. Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE, et al. Severity assessment in asthma: An evolving concept. J Allergy Clin Immunol. 2005;116(5):990-5.
27. Ragab S, Scadding GK, Lund VJ, Saleh H. Treatment of chronic rhinosinusitis and its effects on asthma. Eur Respir J. 2006;28(1):68-74.
28. Moore WC, Peters SP. Severe asthma: an overview. J Allergy Clin Immunol. 2006;117(3):487-94; quiz 495.
29. Strek ME. Difficult asthma. Proc Am Thorac Soc. 2006;3(1):116-23.
30. Sin BA, Akkoca O, Saryal S, Oner F, Misirligil Z. Differences between asthma and COPD in the elderly. J Investig Allergol Clin Immunol. 2006;16(1):44-50.